Capsigen is a leader in the engineering of AAV capsids for use in gene therapies, opening the path to permanent cures for patients suffering from intractable illness. Capsigen is enabling a new era of genetic medicines based on a disease-first approach. Powered by our TRADE™ and data science platforms, we engineer vectors with the highest possible potency and cell-type specificity. Developing genetic medicines that are tailored to the unique biology involved in the disease ensures that the therapy can bring the maximum benefit to patients. Our team is driven in its pursuit to deliver on this promise to the millions of people depending on the advancement of science to discover new cures.
| Website | http://www.capsigen.com |
| Employees | 3 (1 on RocketReach) |
| Founded | 2020 |
| Industry | Biotechnology Research |
| Keywords | Adeno Associated Virus, Gene Therapy, Genetic Engineering, Gene Delivery, Gene Editing, Biotechnology, Advanced Therapies, Viral Vectors, Molecular Biology, Biological Therapies, Drug Development, Innovative Therapies, Clinical Trials, Pharmaceutical, Disease Treatment, Rare Diseases |
| Competitors | Amgen, Invitae, Twist Bioscience, Intellia Therapeutics, Inc., Codexis, Inc., Editas Medicine, GreenLight Biosciences, Zymergen, Inc., Arzeda, Calyxt +32 more (view full list) |
Looking for a particular Capsigen employee's phone or email?
Capsigen Questions
John Bial is the CEO of Capsigen.
1 people are employed at Capsigen.
Capsigen is based in Vancouver, Washington.
Top Capsigen Employees
-
John Bial
Chief Executive Officer at Capsigen
Portland, OR, US14
Related Companies
